Saturn V Capital Management LLC Biogen Inc. Transaction History

Saturn V Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $7.17 Million - $8.63 Million	-32,207 Reduced 49.8%	32,469 $8.4 Billion
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $5.99 Million - $6.76 Million	23,629 Added 57.57%	64,676 $16.6 Billion
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $987,597 - $1.14 Million	3,588 Added 9.58%	41,047 $11.7 Billion
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $7.65 Million - $8.71 Million	29,799 Added 389.02%	37,459 $10.4 Billion
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $1.93 Million - $2.35 Million	7,660 New	7,660 $2.17 Billion

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Saturn V Capital Management LLC with notifications on news.